<DOC>
	<DOCNO>NCT02648399</DOCNO>
	<brief_summary>This study recruit patient unilateral papillary thyroid cancer operation , patient agree enter test , divide experimental control group.experimental group patient receive surgery include unilateral thyroid lobectomy bilateral central lymph node dissection.and control group receive surgery include unilateral thyroid lobectomy unilateral central lymph node dissection.last investigator compare number patient tumor recurrence metastasis rate 5 year , number metastatic lymph node , number participant adverse event relate treatment two group order evaluate significance bilateral lymph node dissection .</brief_summary>
	<brief_title>Prospective Study Clinical Prognosis Bilateral Central Lymph Node Dissection Patients With Unilateral Thyroid Papillary Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Carcinoma , Papillary</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>accord thyroid carcinoma TNM ( tumor , lymph node , metastasis ) stag NCCN ( National Comprehensive Cancer Network ) 1.Unilateral thyroid papillary carcinoma 2.TNM staging : T1~2N0M0 1.Bilateral thyroid papillary carcinoma 2.isthmus thyroid carcinoma 3.TNM staging : T3orT4 4.Clinic N1orM1</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>thyroid carcinoma</keyword>
	<keyword>center lymph node dissection</keyword>
</DOC>